Literature DB >> 17417609

Investigation of founder effects for the Thr377Met Myocilin mutation in glaucoma families from differing ethnic backgrounds.

Alex W Hewitt1, John R Samples, R Rand Allingham, Irma Järvelä, George Kitsos, Subbaiah R Krishnadas, Julia E Richards, Paul R Lichter, Michael B Petersen, Periasamy Sundaresan, Janey L Wiggs, David A Mackey, Mary K Wirtz.   

Abstract

PURPOSE: The aim of this study was to determine if there is a common founder for the Thr377Met myocilin mutation in primary open angle glaucoma (POAG) families with various ethnic backgrounds.
METHODS: Genomic DNA of 24 POAG-affected individuals from nine pedigrees with the Thr377Met mutation and 104 unaffected family members was genotyped with six microsatellite markers and four single nucleotide polymorphisms. The families were from Greece, India, Finland, the USA, and Australia. To assess the degree of linkage disequilibrium across MYOC in the general population we also investigated data generated from the HapMap consortium.
RESULTS: Three distinct haplotypes associated with the Thr377Met myocilin mutation were identified. The families from the USA and Greece, as well as the three Australian families originating from Greece and the former Yugoslavian Republic of Macedonia had one common haplotype. Interestingly, however, HapMap data suggest that linkage disequilibrium across MYOC was not strong.
CONCLUSIONS: The Thr377Met myocilin mutation has arisen at least three separate times. Evidence for genetic founder effects in this prevalent age-related, yet heterogeneous, disease has important implications for future gene identification strategies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17417609      PMCID: PMC2649311     

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


  26 in total

1.  Allele age and a test for selection on rare alleles.

Authors:  M Slatkin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-11-29       Impact factor: 6.237

2.  The structure of haplotype blocks in the human genome.

Authors:  Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler
Journal:  Science       Date:  2002-05-23       Impact factor: 47.728

3.  The International HapMap Project.

Authors: 
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

4.  Estimating the age of rare disease mutations: the example of Triple-A syndrome.

Authors:  E Genin; A Tullio-Pelet; F Begeot; S Lyonnet; L Abel
Journal:  J Med Genet       Date:  2004-06       Impact factor: 6.318

5.  Founder effect in GLC1A-linked familial open-angle glaucoma in Northern France.

Authors:  A P Brézin; M F Adam; A Belmouden; M A Lureau; A Chaventré; B Copin; L Gomez; S D De Dinechin; M Berkani; F Valtot; J F Rouland; J C Dascotte; J F Bach; H J Garchon
Journal:  Am J Med Genet       Date:  1998-04-13

6.  A cellular assay distinguishes normal and mutant TIGR/myocilin protein.

Authors:  Z Zhou; D Vollrath
Journal:  Hum Mol Genet       Date:  1999-11       Impact factor: 6.150

7.  Mutational analysis of the Myocilin gene in patients with primary open-angle glaucoma in Morocco.

Authors:  Rahma Melki; Abderrahmane Idhajji; Said Driouiche; Moustafa Hassani; Abdelaziz Boukabboucha; Omar Akhayat; Henri Garchon; Ahmed Belmouden
Journal:  Ophthalmic Genet       Date:  2003-09       Impact factor: 1.803

8.  Glaucoma phenotype in pedigrees with the myocilin Thr377Met mutation.

Authors:  David A Mackey; Danielle L Healey; John H Fingert; Michael A Coote; Tiffany L Wong; Colleen H Wilkinson; Paul J McCartney; Julian L Rait; A Pauline de Graaf; Edwin M Stone; Jamie E Craig
Journal:  Arch Ophthalmol       Date:  2003-08

9.  Founder TIGR/myocilin mutations for glaucoma in the Québec population.

Authors:  Mathieu Faucher; Jean-Louis Anctil; Marc-André Rodrigue; Annie Duchesne; Dan Bergeron; Pierre Blondeau; Gilles Côté; Stéphane Dubois; Josée Bergeron; Rose Arseneault; Jean Morissette; Vincent Raymond
Journal:  Hum Mol Genet       Date:  2002-09-01       Impact factor: 6.150

10.  Evaluation and understanding of myocilin mutations in Indian primary open angle glaucoma patients.

Authors:  Janakaraj Kanagavalli; Subbaiah Ramasamy Krishnadas; Eswari Pandaranayaka; Sankaran Krishnaswamy; Periasamy Sundaresan
Journal:  Mol Vis       Date:  2003-11-14       Impact factor: 2.367

View more
  6 in total

Review 1.  Glaucoma-associated myocilin: a better understanding but much more to learn.

Authors:  Zachary T Resch; Michael P Fautsch
Journal:  Exp Eye Res       Date:  2008-08-29       Impact factor: 3.467

2.  Association of MYOC and APOE promoter polymorphisms and primary open-angle glaucoma: a meta-analysis.

Authors:  Hui Guo; Minghao Li; Zhe Wang; Qiji Liu; Xinyi Wu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

3.  Primary open angle glaucoma due to T377M MYOC: Population mapping of a Greek founder mutation in Northwestern Greece.

Authors:  George Kitsos; Zacharias Petrou; Maria Grigoriadou; John R Samples; Alex W Hewitt; Haris Kokotas; Aglaia Giannoulia-Karantana; David A Mackey; Mary K Wirtz; Marilita Moschou; John P A Ioannidis; Michael B Petersen
Journal:  Clin Ophthalmol       Date:  2010-03-24

4.  Association of POAG risk factors and the Thr377Met MYOC mutation in an isolated Greek population.

Authors:  Mary K Wirtz; John R Samples; Victoria Toumanidou; Jac Charlesworth; Dimitrios G Mikropoulos; Konstantinos Kaltsos; Athanasios Economou; Antonios Dimopoulos; Irene N Georgiadou; Georgios Moumtzis; Athanasios Papanastasiou; Patricia L Kramer; Tom Dyer; John Blangero; Anastasios G P Konstas
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-27       Impact factor: 4.799

5.  Compound heterozygote myocilin mutations in a pedigree with high prevalence of primary open-angle glaucoma.

Authors:  Thomas K Young; Emmanuelle Souzeau; Lance Liu; Lisa S Kearns; Kathryn P Burdon; Jamie E Craig; Jonathan B Ruddle
Journal:  Mol Vis       Date:  2012-12-28       Impact factor: 2.367

6.  Myocilin variations and familial glaucoma in Taxiarchis, a small Greek village.

Authors:  Mary K Wirtz; Anastasios G P Konstas; John R Samples; Kostantinos Kaltsos; Athanasios Economou; Antonios Dimopoulos; Irene Georgiadou; Michael B Petersen
Journal:  Mol Vis       Date:  2008-04-25       Impact factor: 2.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.